161
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Dose and Schedule Effect of G-GSF for Stem Cell Mobilization in Healthy Donors for Allogeneic Transplantation

&
Pages 1391-1394 | Published online: 01 Jul 2009

  • Bensingcr, W.I., Weaver, C.H., Appelbaum. F.R., Rowley. S., Demircr, T., Sander. J., Storh. R.and Buckner, CD (1995) 'Transplantation of allogeneic peripheral blood stem cells mobilized by recombinanl human granulocyte colony slimukting factor". Blood 85. 1655-1658.
  • Korbling, M., Przepiorka, D., Huh. Y.O., Engel. H., van besien. K., Giralt, S., Andersson, B. Kleine. H.D., Seong, D., Deisseroth. A.B., Andreef. M.and Champlin, R. (1995) "Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts", Blood'86. 2842-2848.
  • Schmilz. N., Bacigalupo. A,. Hasenclever. D., Nagler. A., Gluckman. E., Clark, P., Bourquelot, P., Greinix. H., Frickhofen, N., Ringden. O., Zander, A.R., Apperley, J.F., Gorin. C., Borken. K., Schwab, G. Goebel. M., Russell, N.H. and Gretwohl. A. (1998) "Allogeneic bone marrow transplantation vs. filgrastim-mobilized peripheral blood progenitor cell transplantation in patients with early leukemia: first results of a randomized multicentre trial of the European Group for Blood and Marrow Transplantation", Bone Marrow Transplantation 21, 995-1003
  • Diihrsen. U, Villeval. J.L., Boyd. J., Kannourakis, G. and Metcalf. D.(1988) "Effects of recombinant human granulocyte colonystimulating factor on hemaiopoictic progenitor cells in cancer patients". Blood 72, 2074-2081.
  • Socinski, M.A., Elias. A., Schnipper. L., Cannistra, S.A., Amman. K.H.and Griffin. J.D.(1988) "Granulocytc-macrophage colony stimulating factor expands the circulating haematopoietic progenitor cell compartment in man", l-ancet ii, 1194-1198.
  • Brown, R.A. Adkins, D., DiPersio. J.and Goodnough. T.(1997) "Allogeneic peripheral blood stem cell transplantation is associated with an increased risk of chronic graft versus host diseuse". Blood 90. 225a.
  • Grigg. A.P., Roberts. A.W., Raunow. H., Houghlon, S., Layton, J.E., Boyd. A.W., McGrath. K.M.and Maher. D.(1995) Optimizing dose and scheduling of nlgrastim for mobilisation and collection of peripheral blood progenitor cells in normal volunteers". Blood 86. 4443-4445.
  • Andcrlini. P., Przepiorka. D., Seong, D., Miller, P., Sundberg. J., Lichliger, B., Norfleet, K. Chan. K.W., Champion, R. and Korbling. M.(1996) "Clinical toxicity and laboratory effects of filgrastim mobilization and blood stem cell apheresis from normal donors and analysis of charges for the procedures". Transfusion 36. 590- 595.
  • Tanaka, R., Matsudaira, T., Tanaka, L. Muraoka. K., Ebihara. V., lkebuchi. K.and Nakahata. T.(1994) "Kinetics and characteristics of peripheral blood progenitor cells mobilized by G-CSF in normal healthy volunteers". Blood 84. 541a.
  • Sekhsaria. S., Pleiiher, T.A., Vowells. S., Brown. M., Miller. J., Gordon, J., Blaese. R.M., Dunbar. L.E., Leitman. S.and Maleeh. H.I., (1996) "Granulocyte colony stimulating factor recruitment of CD34+ progenitors to peripheral blood: impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients". Blood 88. 1104-1112.
  • Zeller. W., Stieglitz. J., Dominka, T., Kunde. C., Cassens, U und Zander. A.R.(1993) "Mobilization of blood stem cells using G-CSF without preceding chemotherapy". In: Kretschiner. V., Stange], W. and Eckslein. R., eds. Transfusionsmedizin 1992/93 (Beitr infusionsther. Karger. Freiburg) Vol. 31. pp 168-170.
  • Anderlini. P., Prezpiorka. D., Huh. Y, Uuppe, J., Miller. P., Sundbcrg. J., Scong, D., Champlin. R and Korbling. M.(1996) "Duration of Iilgraslim mobilization and apheresis yield of CD344 progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation", Rritish Journal of Haematohgy 93. 940-942.
  • Watts. M.J., Addison. I., Ings. S.J., Long. S.G., Hartley, S., Warrington, S., Boyce. M.and Linen, D.C. (1998) "Optimal timing for collection of PBSC after glycosylated G-CSF administration". Bone Marrow Transplantation 21, 365-368.
  • Stroncek. D.E.Clay. M.E., Herr. G. Smith. J., Jaszcz. W.B. llstrup. M.and McCullough, J. (1997) "The kinetics of G-CSF mobilization of CD34+ cells in healthy people", Transfusion Medicine 7, 19-24.
  • Stroncek, D.F., Clay. M.E.and Pelzhuldt. M.L.(1996) "Treatmenl of normal individuals with granulocyte stimulaling-factor: donor experiences and the effect on peripheral CD34-I- cell counts and on the collection of peripheral blood stem cells". Transfusion 36. 601-610.
  • Hoglund, M., Smedmyr. B.and Simonsson. B.(1996) "Dosedependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rhuG-CSF'. Bone Marrow Transplantation 18. 279-283.
  • Dreger, P., Hafcrlach, T. Eckstein, V., Jacobs, S. Surtorp. M., Loffler, M., Muller-Ruchholu, W. and Schmilz. N.(1994) "G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft". British Journal of Haemalology 87, 609-613
  • Waller, C.E. Bertz, H., Weiiger. M.K., Fetscher. S., Hardung, M., Engelhardt M., Behrmger, D., Lange. W., Mertelsraunn. R.and Firike. J.(1996) "Mobilization of peripheral blood progenitor cells for allogcnic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen". Bone Murrvw Transplantation 18, 279-283.
  • Kroger. N., Renges. H., Sonnenbcrg. S., Krüger, W., Gutensohn, K., Dielschneider, T., Conez-Dericks. L. Zander. A.R., (2002) "16ug/kg versus 10p-kg of G-CSF for stem cell mobilization for allogeneic transplantation". Bone Marrow Transplantatirm (in press).
  • Engelhardl, M., Benz. H., Afting. M., Waller, C.F. and Finke, J. (1999) "High versus standard dose filgrastim (rhG-CSF) for mobilization of peripheral blood progenitor cells from allogeiieic donors and CD34+ immunoselection", Journal of Clinical Oncology 17, 2160-2172.
  • Martinez, C., Urbano-lspizua, A., Marin, P., Merino, A., Rovira. M., Carreras. E.and Montserrat E.(1999) "Efficacy and loxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors". Bone Marrow Transplantation 24. 1273-1278.
  • de Haas. M., Kersl. J.M., van der School, C., et al., (I994) "Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effect on circulating neutrophils", Blond 84. 3885
  • Arbuna, C., Prosper. R.Bcnet. I.Mena. F.Solano. C.and GarciuCondc. J.(1998) "Comparison between once a day vs. twice a day G-GSF for mobilization of peripheral blood progenitor cells in normal donors for Bllogcneic PBSC transplantation". Bone Marrow Transplantation 22. 39-45.
  • Pönisch, W., Leiblein, S., Edel. E., Haustein, B., Leopold. J., Wolff, D. Hegenbart, U., Becker, C., Lange, T., Skibbe. T., Mockel. J., Schneider, J., Riese. F and Nicderwiescr. D. (2000) 'ThG-CSF mobilzation and collection of peripheral blood progenitor cells in 91 normal donors: comparison between once a day versus twice a day G-CSF administration". Bone Marrow Transplantation 25, 870, supplement.
  • Kroger, N., Renges, H. Krüger, W., Gutcnsohn. K., Löligcr, C., Carrero, I., Cortes, L. and Zander, A.R. (2000) "A rondomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation". British Journal of Haemalology 111. 761 -765
  • Yano, T. Katayama, Y., Sunami. K., Deguchi. S.Nawa. Y., Hiramatsu, Y., Nakayama, H., Arakawa, T., Ishimaru, F., Teshima, T., Shinagawa. K., Omoto. E.and Harada. M (1997) "G-CSF induced mobilization of peripheral blood stem cells forallografting: comparative study of daily single versus divided dose of G-CSF". International Journal of Hematology 66, 169-178.
  • Lee, V., Li. C.K., Shing. M.M., Chik, K.W., Li. K., Tsang. K.S., Zhao, D.C., Lai, D.H., Wong. A.and Yuen, P.M. (2000) "Single vs twice daily G-CSF dose tor peripheral blood stem cell harvest in normal donors and children with non-malignant diseases". Bone Marrow Transplantation 25, 931 -935.
  • Anderlini, P., Donate, M., Lauppe, M.J., Huh. Y.O., Martin, T.G., Chan. K.W., Champlin, R.E. and Körbling. M.(2000) "A comparative study of once-daily versus twice daily filgrastim administration for mobilization and collection of CD34-4 peripheral blood progenitor cells in normal donors". British Journal of Haematalagy 109, 770-772.
  • dc Ia Rubia. J., Murtinez, C., Solano, C., Brunei. S., Cascon. P., Arrieta, R., Alegre. A., Bargay. J., de Arriba, F. Canizo, C., Lope, J., Scrrano, D., Verdeguer, A., Torrabadella. M., Diay, M.A., In sunza, A, de Ia Serna, J., Espigado, I., Petit. J., Martinez, M., Benlloch, L. and Sanz. M.A (1999) "Administration of rccombinam human granulocyte colony stimulating factor to normal donors: results of the Spanish National Donor Registry". Bone Marmw Transplantation 24. 723-728.
  • Brown. R.A., Adkins. D., Goodnough, L.T., Haug, J.S., Todd, G., Wehde. M., Hendricks, D., Ehlenbeck, C., Laub. L.and DiPersio. J.(1997) "Factors that influence the collection and engraftraent of allogeneic peripheral blood stem cells in patients with hrmatologie malignancies". Journal of Clinical Oncology 15, 3067 3074.
  • Becker, P.S. Wagle, M., Matous, S., Swanson, R.S., Pihan. G., Lowry, P.A., Strwart, FM. and Heard, S.O. (1997) "Spontaneous splenic rupture following administration of granulocyte colony stimulating-factor occurrence in an allogeneic donor of peripheral blood stem cells". Biological Blood Marrow 3.45 -49.
  • Murata, M., Harada. M., Kato. S., Takahashi. S., Ogawa. H.,Okamoto, S., Tsuchiya, S., Sakamaki, H., Akiyama. Y, and Kodera, Y. (1999) "Peripheral blood stem cell mobilization an aphcresis: analysis of adverse events in 94 normal donors". Bone Marrow Transplantation 24. 1065- 1071.
  • Adkins, D.R. (1998) "Anaphylactoid reaction in a normal donor (letter)". Journal of Clinical Oncology 16. 812 813.
  • Bensinger, W.I., Buckner, CO., Ruwley, S., Storb. R.and Appclbaum, E.R. (1996) "Treatment of normal donors with recombinanl growth factors for transplantation of allogeneic blood stem cells". Bone Marrow Transplantation 17(2). 19-21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.